Origin Therapeutics Holdings, Inc. (ROVA) Stock Statistics & Valuation Metrics

Origin Therapeutics Holdings, Inc. has a market cap or net worth of CAD 11.30M. The enterprise value is CAD 7.89M.

Market Cap

CAD 11.30M

Enterprise Value

CAD 7.89M

Origin Therapeutics Holdings, Inc. has 205,374,530 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

205,374,530

Owned by Insiders

4.02%

Owned by Institutions

―

Origin Therapeutics Holdings, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-281.84K

Employee Count

3

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, Origin Therapeutics Holdings, Inc. had revenue of ― and earned -845.51K in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

-1.19M

Pretax Income

―

Net Income

-845.51K

EBITDA

-1.19M

Earnings Per Share (EPS)

―

Beta

-0.58

52-Week Price Change

57.14%

50-Day Moving Average

0.06

200-Day Moving Average

0.05

Relative Strength Index (RSI)

51.86

Average Volume (3m)

158.99K

Origin Therapeutics Holdings, Inc. upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).

Last Earnings Date

Aug 31, 2026

Next Earnings Date

Feb 03, 2027

Ex-Dividend Date

―

Origin Therapeutics Holdings, Inc. has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

CAD 0.00

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for Origin Therapeutics Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

709.59%

EPS Growth Forecast

-37.50%